Effects of Testosterone Treatment on Endometrial Proliferation in Postmenopausal Women
Open Access
- 1 June 2007
- journal article
- research article
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 92 (6) , 2169-2175
Abstract
Context: Available data concerning effects of testosterone on endometrium of postmenopausal women are seriously limited. Objective: Our aim was to compare the influence of treatment with testosterone and/or estrogen on endometrial proliferation in healthy postmenopausal women. Design: This was an open, randomized clinical study with parallel comparison of the groups. Setting: The study was conducted at a women’s health clinical research unit and a research laboratory at a university hospital. Participants: Sixty-three women who had experienced natural menopause participated in this study. Interventions: After random assignment, the participants were administered orally testosterone undecanoate (40 mg every second day), estradiol valerate (2 mg daily), or both for 3 months. Main Outcome Measures: Endometrial thickness was measured, and endometrial proliferation evaluated on the basis of histopathol-ogy and expression of Ki-67, a proliferation marker. Results: Endometrial thickness was significantly increased by treatment with estrogen alone or in combination with testosterone but was unaltered by testosterone alone. Among the women receiving estrogen alone, the proportion exhibiting histopathology indicative of proliferation increased significantly to 50% (P < 0.05), there was a nonsignificant increase to 28% with the combined treatment, whereas testosterone alone had no effect at all. Expression of Ki-67 was up-regulated significantly in both glands and stroma (P < 0.05, respectively) in both estrogen treatment groups. However, the expression was significantly higher in stroma by estrogen treatment alone than after combined treatment (P < 0.05). Conclusions: The short-term treatment with testosterone of postmenopausal women does not stimulate endometrial proliferation. In addition, testosterone appears to counteract endometrial proliferation induced by estrogen to a certain extent.Keywords
This publication has 24 references indexed in Scilit:
- Effects of treatment with testosterone alone or in combination with estrogen on insulin sensitivity in postmenopausal womenFertility and Sterility, 2006
- Regulation of Aromatase Expression in Estrogen-Responsive Breast and Uterine Disease: From Bench to TreatmentPharmacological Reviews, 2005
- Evaluation of endometrial steroid receptors and cell mitotic activity in women using copper intrauterine device: Can Cu‐T prevent endometrial cancer?Journal of Obstetrics and Gynaecology Research, 2004
- Attenuation of Estrogenic Effects by Dihydrotestosterone in the Pig Uterus Is Associated with Downregulation of the Estrogen Receptors1Biology of Reproduction, 2004
- Addition of testosterone to estrogen replacement therapy in oophorectomized women: effects on sexuality and well-beingClimacteric, 2002
- Administration of Testosterone Undecanoate in Postmenopausal WomenMenopause, 2000
- Comparison of oral estrogens and estrogens plus androgen on bone mineral density, menopausal symptoms, and lipid-lipoprotein profiles in surgical menopauseObstetrics & Gynecology, 1995
- Affective changes with estrogen and androgen replacement theraphy in surgically menopausal womenJournal of Affective Disorders, 1988
- Histological changes in the genital tract in transsexual women following androgen therapyHistopathology, 1986
- Inability of human endometrium or myometrium to aromatize androstenedioneThe Journal of Steroid Biochemistry and Molecular Biology, 1981